The mission of Boehringer Ingelheim Vetmedica, Inc. is to benefit the health and well-being of mankind by contributing to an adequate supply of safe, nutritious food and by promoting the emotional and physical benefits arising from the human-animal bond.
Boehringer Ingelheim Vetmedica, Inc., headquartered in St. Joseph, Missouri, is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, Connecticut, and is a member of the Boehringer Ingelheim group of companies.
Boehringer Ingelheim Vetmedica, Inc., headquartered in St. Joseph, Missouri, is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, Connecticut, and is a member of the Boehringer Ingelheim group of companies.
News & Announcements
- 27 July 2010 Duramune Lyme Vaccine Approved for Use in Dogs
- 13 June 2010 Bovine Respiratory Disease Takes an Economic Toll on the Herd
- 7 June 2010 Management and Vaccination Keep Trichomoniasis at Bay
- 1 June 2010 Adding to the Bottom Line with Increased Cow Comfort
- 10 May 2010 Moreaux Presented BIVI Equine Leadership Award
- 5 May 2010 Test Herd, Then Treat to Avoid Parasite Resistance
- 5 April 2010 Strong Deworming Program Pays for Itself
- 23 November 2009 Boehringer Ingelheim Introduces New Vetera West Nile Virus Vaccines
